Factors contributing the outcome of Schizophrenia in developing and developed countries: A brief review

Authors

  • Mahmuda Naheed Faculty of Health Science, Department of Pharmacy, Northern University Bangladesh, Dhaka
  • Khondoker Ayesha Akter 1aculty of Health Science, Department of Pharmacy, Northern University Bangladesh, Dhaka
  • Fatema Tabassum Faculty of Health Science, Department of Pharmacy, Northern University Bangladesh, Dhaka
  • Rumana Mawla Faculty of Pharmacy, Dept. of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka
  • Mahmudur Rahman Faculty of Health Science, Department of Pharmacy, Northern University Bangladesh, Dhaka

DOI:

https://doi.org/10.3329/icpj.v1i4.10063

Keywords:

Schizophrenia, outcome, developing countries, antipsychotic agents

Abstract

According to WHO, schizophrenia is a severe form of mental illness affecting about 7 per thousand of the adult popu-lation, mostly in the age group 15-35 years. Though the incidence is low (3-10,000), the prevalence is high due to chronicity. Schizophrenia is occurring in both developing and developed countries. The remission rate is higher in developing countries compared to the developed ones. There are some compelling factors that may influence the out-come of schizophrenia includes gender, employment, marital status, family support, illness myths, family burden, duration of untreated psychosis etc. In this review we have discussed the epidemiology, pathophysiology, diagnosis, treatment and finally the factors that influence the outcome of schizophrenia in developing and developed countries.

Key Words: Schizophrenia, outcome, developing countries, antipsychotic agents.

DOI: http://dx.doi.org/10.3329/icpj.v1i4.10063

International Current Pharmaceutical Journal 2012, 1(4): 81-85

 

Downloads

Download data is not yet available.
Abstract
1158
PDF
1813

Downloads

How to Cite

Naheed, M., Akter, K. A., Tabassum, F., Mawla, R., & Rahman, M. (2012). Factors contributing the outcome of Schizophrenia in developing and developed countries: A brief review. International Current Pharmaceutical Journal, 1(4), 81–85. https://doi.org/10.3329/icpj.v1i4.10063

Issue

Vol. 1 No. 4 (2012)

Section

Review Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).